Tenaya Therapeutics to Participate at the 21st Annual Morgan Stanley Global Healthcare Conference
01 9월 2023 - 5:05AM
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage
biotechnology company with a mission to discover, develop and
deliver potentially curative therapies that address the underlying
causes of heart disease, today announced that Faraz Ali, Chief
Executive Officer, will participate in the 21st Annual Morgan
Stanley Global Healthcare Conference taking place in New York City.
Details of participation are as follows:
Fireside ChatDate: September 12, 2023Time: 11:55 AM PT / 2:55 PM
ET
A webcast of the event will be available for approximately 90
days by visiting the Investors section of Tenaya’s website. An
updated version of Tenaya’s corporate presentation is also
available on the company’s website.
About Tenaya Therapeutics Tenaya Therapeutics
is a clinical-stage biotechnology company committed to a bold
mission: to discover, develop and deliver potentially curative
therapies that address the underlying drivers of heart disease.
Leveraging its integrated and interrelated Gene Therapy, Cellular
Regeneration and Precision Medicine platforms and proprietary core
capabilities, the company is advancing a pipeline of novel
therapies with diverse treatment modalities for rare genetic
cardiovascular disorders and more prevalent heart conditions.
Tenaya’s most advanced candidates include TN-201, a gene therapy
for MYBPC3-associated hypertrophic cardiomyopathy (HCM), TN-401, a
gene therapy for PKP2-associated arrhythmogenic right ventricular
cardiomyopathy (ARVC), and TN-301, a small molecule HDAC6 inhibitor
being initially developed for heart failure with preserved ejection
fraction (HFpEF). Tenaya also has multiple early-stage programs
progressing through preclinical development. For more information,
visit www.tenayatherapeutics.com.
Contacts
InvestorsMichelle CorralVice President,
Investor Relations and Corporate CommunicationsTenaya
TherapeuticsIR@tenayathera.com
MediaWendy RyanTen Bridge
Communicationswendy@tenbridgecommunications.com
Tenaya Therapeutics (NASDAQ:TNYA)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Tenaya Therapeutics (NASDAQ:TNYA)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024